GBIO - Generation Bio Co Stock Price, Fair Value and News

$1.19+0.11 (+10.19%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

GBIO Price Action

Last 7 days

2.6%

Last 30 days

-11.8%

Last 90 days

-57.2%

Trailing 12 Months

-35.3%

GBIO RSI Chart

GBIO Valuation

Market Cap

79.5M

Price/Earnings (Trailing)

-0.55

Price/Sales (Trailing)

4.28

Price/Free Cashflow

-0.76

GBIO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

GBIO Fundamentals

GBIO Revenue

Revenue (TTM)

18.6M

Rev. Growth (Yr)

252%

Rev. Growth (Qtr)

84.65%

GBIO Earnings

Earnings (TTM)

-145.5M

Earnings Growth (Yr)

45.83%

Earnings Growth (Qtr)

25.05%

GBIO Profitability

Return on Equity

-139.28%

Return on Assets

-58.47%

Free Cashflow Yield

-131.3%

GBIO Investor Care

Shares Dilution (1Y)

1.08%

Diluted EPS (TTM)

-2.19

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	10.0M	13.2M	18.6M	0
2023	0	0	0	5.9M
2018	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

About Generation Bio Co

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

CEO	Dr. Cameron Geoffrey McDonough M.D.
WEBSITE	https://generationbio.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	150

Generation Bio Co Frequently Asked Questions

What is the ticker symbol for Generation Bio Co? What does GBIO stand for in stocks?

GBIO is the stock ticker symbol of Generation Bio Co. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Generation Bio Co (GBIO)?

As of Fri Dec 20 2024, market cap of Generation Bio Co is 79.48 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of GBIO stock?

You can check GBIO's fair value in chart for subscribers.

Is Generation Bio Co a good stock to buy?

The fair value guage provides a quick view whether GBIO is over valued or under valued. Whether Generation Bio Co is cheap or expensive depends on the assumptions which impact Generation Bio Co's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for GBIO.

What is Generation Bio Co's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, GBIO's PE ratio (Price to Earnings) is -0.55 and Price to Sales (PS) ratio is 4.28. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. GBIO PE ratio will change depending on the future growth rate expectations of investors.